MDxHealth is trading 12.49% up at $0.77 amid broader pre-market strength; no confirmed company-specific catalyst was identified.

  • The stock closed at $0.68 on September 16, 2026.
  • No new company press release dated September 16 or September 17 was identified, and available coverage does not link the move to a specific corporate event.
  • S&P 500, Nasdaq Composite and Dow futures are all up more than 0.5% pre-market, suggesting global risk-on sentiment may be contributing.